138 related articles for article (PubMed ID: 27206918)
41. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
Low PS; Henne WA; Doorneweerd DD
Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
[TBL] [Abstract][Full Text] [Related]
42. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery.
Chandrasekar D; Sistla R; Ahmad FJ; Khar RK; Diwan PV
J Biomed Mater Res A; 2007 Jul; 82(1):92-103. PubMed ID: 17269145
[TBL] [Abstract][Full Text] [Related]
43. Macrophages and their products in rheumatoid arthritis.
Szekanecz Z; Koch AE
Curr Opin Rheumatol; 2007 May; 19(3):289-95. PubMed ID: 17414958
[TBL] [Abstract][Full Text] [Related]
44. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
45. Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression.
Hosoya T; Iwai H; Yamaguchi Y; Kawahata K; Miyasaka N; Kohsaka H
Ann Rheum Dis; 2016 Jan; 75(1):253-9. PubMed ID: 25165034
[TBL] [Abstract][Full Text] [Related]
46. Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-alpha 4 antibody in adjuvant arthritis.
Barbadillo C; G-Arroyo A; Salas C; Mulero J; Sánchez-Madrid F; Andreu JL
Springer Semin Immunopathol; 1995; 16(4):427-36. PubMed ID: 7570293
[No Abstract] [Full Text] [Related]
47. Folate-targeted verrucarin A reduces the number of activated macrophages in a mouse model of acute peritonitis.
Venkatesh C; Doorneweerd DD; Xia W; Putt KS; Low PS
Bioorg Med Chem Lett; 2021 Jun; 42():128091. PubMed ID: 33964441
[TBL] [Abstract][Full Text] [Related]
48. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
[TBL] [Abstract][Full Text] [Related]
49. Folate-linked drugs for the treatment of cancer and inflammatory diseases.
Yang J; Vlashi E; Low P
Subcell Biochem; 2012; 56():163-79. PubMed ID: 22116699
[TBL] [Abstract][Full Text] [Related]
50. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
[TBL] [Abstract][Full Text] [Related]
51. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
Whittle SL; Hughes RA
Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
[TBL] [Abstract][Full Text] [Related]
52. Predicting Response to Therapy for Autoimmune and Inflammatory Diseases Using a Folate Receptor-Targeted Near-Infrared Fluorescent Imaging Agent.
Kelderhouse LE; Mahalingam S; Low PS
Mol Imaging Biol; 2016 Apr; 18(2):201-8. PubMed ID: 26242480
[TBL] [Abstract][Full Text] [Related]
53. Imaging of activated macrophages in experimental osteoarthritis using folate-targeted animal single-photon-emission computed tomography/computed tomography.
Piscaer TM; Müller C; Mindt TL; Lubberts E; Verhaar JA; Krenning EP; Schibli R; De Jong M; Weinans H
Arthritis Rheum; 2011 Jul; 63(7):1898-907. PubMed ID: 21437875
[TBL] [Abstract][Full Text] [Related]
54. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
55. Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis.
Fernandes JC; Wang H; Jreyssaty C; Benderdour M; Lavigne P; Qiu X; Winnik FM; Zhang X; Dai K; Shi Q
Mol Ther; 2008 Jul; 16(7):1243-51. PubMed ID: 18500247
[TBL] [Abstract][Full Text] [Related]
56. Folic acid-functionalized human serum albumin nanocapsules for targeted drug delivery to chronically activated macrophages.
Rollett A; Reiter T; Nogueira P; Cardinale M; Loureiro A; Gomes A; Cavaco-Paulo A; Moreira A; Carmo AM; Guebitz GM
Int J Pharm; 2012 May; 427(2):460-6. PubMed ID: 22374516
[TBL] [Abstract][Full Text] [Related]
57. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
[TBL] [Abstract][Full Text] [Related]
58. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
Paulos CM; Reddy JA; Leamon CP; Turk MJ; Low PS
Mol Pharmacol; 2004 Dec; 66(6):1406-14. PubMed ID: 15371560
[TBL] [Abstract][Full Text] [Related]
59. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.
Hornung N; Ellingsen T; Stengaard-Pedersen K; Poulsen JH
J Rheumatol; 2004 Dec; 31(12):2374-81. PubMed ID: 15570637
[TBL] [Abstract][Full Text] [Related]
60. [Future perspectives on tumor-specific immunotherapy using hapten-reactive T cell activity].
Hamaoka T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):886-96. PubMed ID: 2786376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
